Minimal Effective Dose
Minimal Effective Dose is a dosing concept in immuno-oncology that denotes the lowest dose of an immunotherapeutic agent required to achieve a clinically meaningful and sustained antitumor immune response.
802
Publications
36K
Citations
3.4K
Authors
1.1K
Institutions
Publications per year
2017–2026
90
802
1–5 of 802
3.4K
The University of Texas Southwestern Medical Center, United States
8 publications · 360 citations
8
h-index
6
h-index
5
h-index
3
h-index
3
h-index
1–5 of 3.4K
1.1K
Harvard University
Cambridge, United States
16 h-index
42 publications
2.2K citations

University of Toronto
Toronto, Canada
8 h-index
37 publications
2.3K citations
Inserm
Paris, France
7 h-index
29 publications
2.4K citations
The University of Texas Southwestern Medical Center
Dallas, United States
7 h-index
31 publications
590 citations
Utrecht University
Utrecht, The Netherlands
7 h-index
11 publications
252 citations
Emory University
Atlanta, United States
7 h-index
18 publications
406 citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
7 h-index
27 publications
1.8K citations
University of California, San Francisco
San Francisco, United States
7 h-index
14 publications
529 citations
1–8 of 1.1K
Repository · 91 publications · 3.1K citations
30
h-index
AAC · 24 publications · 1.3K citations
21
h-index
30 publications · 1.4K citations
19
h-index
27 publications · 907 citations
17
h-index
17 publications · 747 citations
15
h-index
1–5